NCT03302273View on ClinicalTrials.gov

Corneal Epithelial Stem Cells and Dry Eye Disease

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2022

Conditions
Dry Eye SyndromesDry EyeOcular InflammationOcular Surface DiseaseOcular DiscomfortBlepharitis
Interventions
OTHER

Corneal Epithelial Stem Cell Transplant

Self-administration of formulated topical eye drops containing cadaveric epithelial stem cell-derived biologic material.

Trial Locations (1)

79109

Rush Eye Associates, Amarillo

All Listed Sponsors
lead

Sloan W. Rush, MD

OTHER

NCT03302273 - Corneal Epithelial Stem Cells and Dry Eye Disease | Biotech Hunter | Biotech Hunter